id stringlengths 32 32 | url stringlengths 31 1.58k | title stringlengths 0 1.02k | contents stringlengths 92 1.17M |
|---|---|---|---|
f73e0fac39b4aa0842e12523f288c6b3 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSN2036914620090520 | US Senate panel backs FDA oversight of cigarettes | US Senate panel backs FDA oversight of cigarettes
By Reuters Staff3 Min Read
*Full Senate must now vote on bill
*Republicans: need to fight issue head on
*Some senators cite regulatory burdens for small cos.
WASHINGTON, May 20 (Reuters) - A U.S. Senate panel on Wednesday backed legislation that would give the Food and ... |
639f0dd92c5b23454aab6333b655fd71 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSN2230228020081023 | Beyonce would like to be known as 'Sasha Fierce' | Beyonce would like to be known as 'Sasha Fierce'
By Reuters Life!2 Min Read
LOS ANGELES, Oct 22 (Reuters Life!) - Just like the “Seinfeld” episode where George wanted everyone to call him “T-Bone,” Beyonce Knowles would like to be known by a bold new name.
The R&B singer has christened herself “Sasha Fierce” for her ne... |
4bc6da228dae12acc4bbcfdbda2a6cf4 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSN2253860820080123 | Chrysler CEO says Fed rate cut to boost auto sales | Chrysler CEO says Fed rate cut to boost auto sales
By Reuters Staff1 Min Read
DETROIT, Jan 22 (Reuters) - Chrysler Chief Executive Bob Nardelli on Tuesday said the Federal Reserve’s rate cut would help ease consumer confidence and boost auto sales in 2008.
“We are very pleased with the cut,” Nardelli told reporters on ... |
1c9332e71350076fa09c3bc5e8c593f1 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSN2865148420071129 | Tesla names CEO ahead of electric Roadster launch | Tesla names CEO ahead of electric Roadster launch
By Reuters Staff2 Min Read
SAN FRANCISCO, Nov 28 (Reuters) - Tesla Motors named a veteran Silicon Valley entrepreneur and car enthusiast as its new chief executive on Wednesday as the company starts production next quarter of the all-electric Roadster sports car.
Ze’ev ... |
1e80416a6babbdb663ba26afba0d6720 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSSEO5436820081210 | S.Korea lifts rule on mobile platform, opens market | S.Korea lifts rule on mobile platform, opens market
By Reuters Staff2 Min Read
SEOUL, Dec 10 (Reuters) - South Korea said on Wednesday it would lift a rule that forces handsets sold domestically to use a locally developed mobile device platform, opening the market to more foreign cellphones.
South Korean regulators req... |
31569c9fc97ae077a42d75a20505215c | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUST33472320080911 | Honda, Yamaha target electric motorbike launch-paper | Honda, Yamaha target electric motorbike launch-paper
By Reuters Staff2 Min Read
TOKYO, Sept 11 (Reuters) - Japan's Honda Motor Co 7267.T and Yamaha Motor Co 7272.T have set launch dates for electric motorcycles, the Nikkei business daily reported on Thursday.
Yamaha aims to launch electric motorcycles by 2010 with a ra... |
9cc59100a3eca448acc5eb42144e6327 | https://www.reuters.com/article/rbssConsumerGoodsAndRetailNews/idUSTP12793120090731 | UPDATE 1-Smartphone firm HTC sees revenue fall on product delay | UPDATE 1-Smartphone firm HTC sees revenue fall on product delay
By Reuters Staff3 Min Read
* Cuts revenue forecast on product delay, cheaper phones
* Expects to maintain gross margins at around 32 percent
* Revenue fall would lag overall sector growth
* Shares up 36 pct this year vs 54 pct on main board (Recasts with q... |
890a685469c25d409c3f458df46819d5 | https://www.reuters.com/article/rbssEnergyNews/idUKL162650420080716?edition-redirect=uk | U.S. energy firm Vanco in arbitration with Ukraine | U.S. energy firm Vanco in arbitration with Ukraine
By Reuters Staff3 Min Read
KIEV, July 16 (Reuters) - U.S. energy company Vanco said on Wednesday it had filed for international arbitration with Ukraine, after the government cancelled a 30-year licence to explore and extract oil and gas in the Black Sea shelf.
Prime M... |
b660365c18eaf34d535d63c954540bcb | https://www.reuters.com/article/rbssEnergyNews/idUKL2150308920080121?edition-redirect=uk | Finland tells Nord Stream to study alternative routes | Finland tells Nord Stream to study alternative routes
By Reuters Staff3 Min Read
HELSINKI (Reuters) - Finland insists the Nord Stream consortium conduct a thorough environmental impact study of an alternative, southern route for its planned gas pipeline under the Baltic Sea, the environment ministry said on Monday.
A w... |
4c0c59cdfac49794cab91894bdf2f21d | https://www.reuters.com/article/rbssEnergyNews/idUKLI71733420090218?edition-redirect=uk | RPT-UPDATE 5-Russian LNG plant extends Kremlin's energy reach | RPT-UPDATE 5-Russian LNG plant extends Kremlin's energy reach
By Tanya Mosolova, Denis Dyomkin5 Min Read
(Repeats to additional subscribers)
(Adds Deputy PM Sechin comment in paragraph 6)
PRIGORODNOYE, Russia, Feb 18 (Reuters) - Russia inaugurated a $22 billion Pacific natural gas project on Wednesday that will allow t... |
bd8a018233f4061f9a83f23f9fe0fdd4 | https://www.reuters.com/article/rbssEnergyNews/idUKN2334392320090423?edition-redirect=uk | RPT-Shell agrees to settle TX refinery pollution suit | RPT-Shell agrees to settle TX refinery pollution suit
By Erwin Seba3 Min Read
(Repeats to additional subcribers with no changes to text)
HOUSTON, April 23 (Reuters) - Shell Oil Co, the Sierra Club and a Texas environmental group have agreed on Thursday to settle a federal Clean Air Act lawsuit against Shell’s Houston-a... |
1186ce5473e5a626f4915cda22419615 | https://www.reuters.com/article/rbssEnergyNews/idUSB76113820090610?rpc=401 | Total cuts Sanofi-Aventis stake to below 10 percent | Total cuts Sanofi-Aventis stake to below 10 percent
By Reuters Staff1 Min Read
PARIS, June 10 (Reuters) - French oil and gas company Total TOTF.PA has cut its stake in pharmaceuticals group Sanofi-Aventis SASY.PA to under 10 percent, French market regulator AMF said in a statement on Wednesday.
Total now holds 9.99 per... |
4bb33f107d1eb59f2da458e0cd81bbac | https://www.reuters.com/article/rbssEnergyNews/idUSHKG7667320080812 | China's CNOOC Ltd makes new Bohai Bay discovery | China's CNOOC Ltd makes new Bohai Bay discovery
By Reuters Staff1 Min Read
HONG KONG, Aug 12 (Reuters) - Chinese offshore oil driller CNOOC Ltd said on Tuesday it had made a new oil and gas discovery with a wildcat well in the Bohai Bay in northern China.
The BZ29-5-1 well, drilled to a total depth of 1,885 metres (6,1... |
ec3b196739d17784684744bcc58fceb2 | https://www.reuters.com/article/rbssEnergyNews/idUSL0479359220080305 | FACTBOX: Russia's Dmitry Medvedev: his inner circle | FACTBOX: Russia's Dmitry Medvedev: his inner circle
By Reuters Staff4 Min Read
(Reuters) - Russia’s president-elect, Dmitry Medvedev, has just over two months to assemble his administration team before he is sworn in to take over from his mentor President Vladimir Putin.
Analysts say there is a question mark over wheth... |
bfbaded7612da4c0a145040a74d32d54 | https://www.reuters.com/article/rbssEnergyNews/idUSL1725382020080717 | REFILE-Russia's TNK-BP employees suing CEO Dudley - Ifax | REFILE-Russia's TNK-BP employees suing CEO Dudley - Ifax
By Reuters Staff2 Min Read
(Corrects spelling of “suing” in headline)
MOSCOW, July 17 (Reuters) - A group of employees at BP's BP.L troubled Russian oil venture TNK-BP have filed a lawsuit against the firm's chief executive, accusing him of mismanaging the compan... |
58f91b7897961498bb568903bf94222b | https://www.reuters.com/article/rbssEnergyNews/idUSLB36242020080811 | Gazprom Neft offers own assets in Kazakh MMG bid | Gazprom Neft offers own assets in Kazakh MMG bid
By Reuters Staff2 Min Read
ALMATY, Aug 11 (Reuters) - Russia’s Gazprom Neft will offer Kazakhstan a stake in one of its own projects in exchange for a 49 percent stake in Kazakh oil firm MangistauMunaiGas (MMG), a senior Gazprom Neft official said.
Kazakh state oil and g... |
2abfb632b369a6761b63d5d728d4336b | https://www.reuters.com/article/rbssEnergyNews/idUSLB51814620090911 | MOL sells $4 mln in shares to finance gas project | MOL sells $4 mln in shares to finance gas project
By Reuters Staff1 Min Read
BUDAPEST, Sept 11 (Reuters) - Hungarian oil group MOL MOLB.BU sold 47,369 of its own shares on the Budapest Stock Exchange on Thursday, it said on Friday, raising about 675 mln forints ($3.57 million) to help finance a gas project in Iraq.
The... |
5e1adb285e21a4c6a1632dacc617cef3 | https://www.reuters.com/article/rbssEnergyNews/idUSSYD23502720080717 | Australia's Nexus plans $975 mln gas exploration | Australia's Nexus plans $975 mln gas exploration
By Reuters Staff2 Min Read
DARWIN, Australia, July 17 (Reuters) - Australian energy firm Nexus Energy Ltd NXS.AX plans to spend about A$1 billion ($975 million) on exploration over the next three years to secure more gas reserves that could help support a liquefied natur... |
d8f1b77cf55c0dfe2ac8c1689a493947 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idINBKK47086420090408?edition-redirect=in | UPDATE 4-Anti-govt rally in Bangkok, PM says Asia summit on | UPDATE 4-Anti-govt rally in Bangkok, PM says Asia summit on
By Kittipong Soonprasert5 Min Read
* PM Abhisit says Asian summit will go ahead this week
* Number of protesters smaller than organisers expected
* Thaksin asks protesters to stay “three more days”
BANGKOK, April 8 (Reuters) - Thai Prime Minister Abhisit Vejja... |
0cfab5d4497a7d0e8b321585a3a41932 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idINLDE62018K20100301?edition-redirect=in | Islamic finance industry launches derivatives standard | Islamic finance industry launches derivatives standard
By Reuters Staff2 Min Read
MANAMA, March 1 (Reuters) - A template for an over-the-counter Islamic derivative contract was launched on Monday, offering a channel for the emerging industry to better hedge itself against risks.
The contract, in the making for three ye... |
de69fc1e57f3d9e5f6976b219e13fd08 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUKLM13829220090122?edition-redirect=uk | Fortis Bank to report 2008 loss up to 19 bln euros | Fortis Bank to report 2008 loss up to 19 bln euros
By Reuters Staff2 Min Read
BRUSSELS, Jan 22 (Reuters) - Fortis Bank, principally owned by the Belgian state, said on Thursday it made a 14.1 billion euro ($18.30 billion) net loss in the first nine months of 2008 and expected a further 4 to 5 billion euro loss in the f... |
1c61a2882bcb287d98eb14646540f819 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUKN0340867220090503?edition-redirect=uk | UPDATE 1-Buffett faults stress test, defends bank holdings | UPDATE 1-Buffett faults stress test, defends bank holdings
By Jonathan Stempel, Lilla Zuill3 Min Read
(Adds of Buffett, Munger comments, bylines)
OMAHA, Neb., May 3 (Reuters) - Warren Buffett criticized the government's stress tests of 19 large U.S. banks for failing to account for strengths in lenders' business models... |
adf90138b4075831b056d9522c341650 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUKN2333388820090223?edition-redirect=uk | Ticketmaster, NJ settle over Springsteen ticket sales | Ticketmaster, NJ settle over Springsteen ticket sales
By Reuters Staff3 Min Read
WASHINGTON, Feb 23 (Reuters) - Ticketmaster TKTM.O settled with New Jersey to resolve more than 2,000 complaints over the company's handling of ticket sales to see Bruce Springsteen concerts, the New Jersey attorney general's office said o... |
5f9030899bb913feebd3ef9a90654614 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUKN2646483420080628?edition-redirect=uk | Warren Buffett lunch sells for record $2.11 mln | Warren Buffett lunch sells for record $2.11 mln
By Reuters Staff3 Min Read
NEW YORK, June 27 (Reuters) - It takes millions to have lunch with someone who control billions.
A bidder agreed to pay $2.11 million to have lunch with billionaire Warren Buffett, more than triple last year’s record for the annual charity aucti... |
54b32fde2a1799fb29b7eae41ce0f8a9 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSLD61731220091013 | Bailed-out British bank RBS to open up art vault | Bailed-out British bank RBS to open up art vault
By Reuters Life!2 Min Read
* RBS to open up 2,200 piece art collection
* Includes pieces by leading British artists
LONDON, Oct 13 (Reuters Life!) - Royal Bank of Scotland RBS.L plans to widen access to its private art collection as part of efforts to rebuild its image a... |
0b9ac0a8c26c1d38af8b9e5438c7c9c4 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSLH62517620090417 | Iceland PM-Kaupthing assets cover German deposits | Iceland PM-Kaupthing assets cover German deposits
By Reuters Staff1 Min Read
REYKJAVIK, April 17 (Reuters) - Icelandic Prime Minister Johanna Sigurdardottir said on Friday the assets of Kaupthing would be enough to pay back all the German depositors who held EDGE accounts in the failed bank.
“It has now become clear ..... |
50f6340ef72de921f4ea7c5140655765 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSLJ60083720080919 | Pension funds stick by equities despite crisis | Pension funds stick by equities despite crisis
By Cecilia Valente4 Min Read
LONDON, Sept 19 (Reuters) - Europe’s two largest pension schemes, with a total of about $705 billion in assets, said they would adhere to existing allocations to equities as part of their long-term strategy, despite the sustained market turmoil... |
a9043344596958573ddd30d0987c621c | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN0214772420090521 | FACTBOX-U.S. bank failures in 2009 | FACTBOX-U.S. bank failures in 2009
By Reuters Staff0 Min Read
WASHINGTON, May 21 (Reuters) - Following is a list of U.S. bank failures so far this year, according to the Federal Deposit Insurance Corp.
Details about each bank closure are postedhere.
U.S. BANK FAILURES IN 2009**
(assets, deposits, FDIC cost in million d... |
ea1d127dced1bf98140d4c906bef01cd | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN1447657420090514 | UPDATE 2-JP Morgan's notes weaken as bond rally fizzles | UPDATE 2-JP Morgan's notes weaken as bond rally fizzles
By Reuters Staff3 Min Read
(Adds background, updates bond spreads)
NEW YORK, May 14 (Reuters) - A $2.5 billion issue of notes sold by JP Morgan Chase & Co JPM.N on Wednesday weakened in secondary trading on Thursday in the latest sign that a corporate bond rally i... |
0e20a10a969c1235788dc85cb8a26aa2 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN1453119720081014 | UPDATE 1-Synacor pulls IPO, cites market conditions | UPDATE 1-Synacor pulls IPO, cites market conditions
By Reuters Staff3 Min Read
NEW YORK, Oct 14 (Reuters) - Synacor Inc, which provides an Internet platform and digital content for broadband service companies, withdrew its application on Tuesday for an initial public offering, citing market conditions, according to a r... |
ece3dc7940838cca01d0786d8ad6275a | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN2415584020090624 | US credit card chargeoffs break new record - Moody's | US credit card chargeoffs break new record - Moody's
By Reuters Staff3 Min Read
* Chargeoff rate rises over 10 percent for the first time
* Moody’s sees chargeoffs peaking at around 12 percent
* Moody’s says bad loans will peak in Q2 2010
NEW YORK, June 24 (Reuters) - The U.S. monthly credit card chargeoff rate surpass... |
919951a4ff839fcffcfa054ed54a772e | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN2551667820090925 | UPDATE 1-Stiglitz says stocks a poor indicator for economy | UPDATE 1-Stiglitz says stocks a poor indicator for economy
By Jonathan Stempel4 Min Read
* Stocks could rise even if economy struggles
* Markets “tilted” toward too-big-to-fail companies (New throughout, adds byline)
NEW YORK, Sept 25 (Reuters) - Nobel economist Joseph Stiglitz said on Friday a rising stock market is n... |
34a251d5fac54193b8b36ee8525c8c48 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSN2620074020091026 | US consumer advocates warn of gift card costs | US consumer advocates warn of gift card costs
By Reuters Staff2 Min Read
WASHINGTON, Oct 26 (Reuters) - Most consumers do not know that it costs $4 to $7 to buy a general purpose gift card or that they may be subject to monthly fees of up to $4.95 as soon as six months after the card is purchased, consumer advocates sa... |
7d5525b69b7b6dac9a645c33b4ac495e | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSSIN12899920081020 | Arcapita hires Lehman exec for Asia real estate unit | Arcapita hires Lehman exec for Asia real estate unit
By Reuters Staff1 Min Read
SINGAPORE, Oct 20 (Reuters) - Bahrain investment bank Arcapita has hired a former Lehman Brothers’ real estate executive to lead its Asian property team in Singapore, the bank said on Monday.
Blake Olafson joins Arcapita after serving colla... |
01e3615524805bb12a1bbc3096ff8b7d | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUSSP47327420090831?pageNumber=2&virtualBrandChannel=11604 | UPDATE 1-Beijing's derivative default stance rattles banks | UPDATE 1-Beijing's derivative default stance rattles banks
By 6 Min Read
* State-owned firms may default on commodity hedges - report
* Bankers dismayed, confused by report; seek more details
* Lawyers question legality of the move
* Traders suspect lurking losses may have prompted warning (Adds analysts comments)
By E... |
1c46dda0f0ec8dd7bed07afc7e2e73a9 | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUST13774020081009 | UPDATE 1-Japan's first REIT fails, hit by credit crunch | UPDATE 1-Japan's first REIT fails, hit by credit crunch
By Junko Fujita3 Min Read
(Adds background)
TOKYO, Oct 9 (Reuters) - New City Residence Investment Corp 8965.T said it filed for court protection from creditors with $1.1 billion in debt, the first Japanese real estate investment trust to fail as fallout from the ... |
ed73ff1640dbd932146a05cc6486ea4c | https://www.reuters.com/article/rbssFinancialServicesAndRealEstateNews/idUST15087320081010 | UPDATE 2-Japan's Yamato Life fails with $2.7 bln in debt | UPDATE 2-Japan's Yamato Life fails with $2.7 bln in debt
By Leika Kihara, Taiga Uranaka3 Min Read
(For more stories on the global crisis, click [ID:nCRISIS]) (Adds details)
TOKYO, Oct 10 (Reuters) - Japan’s Yamato Life Insurance Co, an unlisted midsized insurer, failed with $2.7 billion in debt on Friday, the first Jap... |
91d0a5e1ab983b549ce806ed1fa32ef8 | https://www.reuters.com/article/rbssHealthcareNews/idUKL131930820080613?edition-redirect=uk | UPDATE 1-Roche's Actemra helps in hard-to-treat arthritis | UPDATE 1-Roche's Actemra helps in hard-to-treat arthritis
By Sam Cage3 Min Read
(Adds details from statement, background)
ZURICH, June 13 (Reuters) - Thirty percent of rheumatoid arthritis patients who failed to respond adequately to anti-TNF therapy achieved remission from their disease when given Roche's ROG.VX new d... |
ca551288f430eb589024bbd1d985e101 | https://www.reuters.com/article/rbssHealthcareNews/idUSB17590520090602 | UPDATE 1-Novartis launches 1.5 bln euro 2016 bond | UPDATE 1-Novartis launches 1.5 bln euro 2016 bond
By Reuters Staff1 Min Read
(Adds detail)
ZURICH, June 2 (Reuters) - Swiss drugmaker Novartis AG NOVN.VX said on Tuesday it had launched a seven-year 1.5 billion euro ($2.1 billion) bond issue with a coupon of 4.25 percent.
The note maturing on June 15, 2016 was priced a... |
450f8f457790520e7452ccbcbb56eb7f | https://www.reuters.com/article/rbssHealthcareNews/idUSBNG14697020090706 | UPDATE 2-Caraco cuts half its workforce on production stoppage | UPDATE 2-Caraco cuts half its workforce on production stoppage
By Reuters Staff3 Min Read
* Cuts 52 percent of its workforce, or 350 jobs
* Caraco: JPMorgan Chase says line of credit not available
* Caraco shares down 4 pct (Adds background)
July 6 (Reuters) - Caraco Pharmaceutical Laboratories Ltd CPD.A said it would ... |
2c8781b3186ffd2e5f1db003ba9365f4 | https://www.reuters.com/article/rbssHealthcareNews/idUSBNG35549320090727 | UPDATE 1-Mylan workers sidestepped quality controls -report | UPDATE 1-Mylan workers sidestepped quality controls -report
By Reuters Staff3 Min Read
(Adds comments from Mylan statement in first, fifth paragraphs)
July 27 (Reuters) - Drugmaker Mylan Inc refuted a newspaper report its staff overrode government-mandated quality controls, saying the report was based on improperly obt... |
bcd008d3d91b470d7abb25081d137be5 | https://www.reuters.com/article/rbssHealthcareNews/idUSBNG49336220090518?rpc=401 | UPDATE 1-J&J unit's bipolar drug gets FDA approval | UPDATE 1-J&J unit's bipolar drug gets FDA approval
By Reuters Staff2 Min Read
May 18 (Reuters) - Johnson & Johnson's JNJ.N unit Janssen Pharmaceuticals said U.S. health regulators broadened the approval of its antipsychotic agent, Risperdal Consta, for the treatment of bipolar I disorder.
The drug, which has already be... |
2de2d6b16aadc66904b6dc52df0db511 | https://www.reuters.com/article/rbssHealthcareNews/idUSBNG49763820090602 | UPDATE 1-Takeda suspending stock buybacks - Nikkei | UPDATE 1-Takeda suspending stock buybacks - Nikkei
By Reuters Staff1 Min Read
June 3 (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical Co 4502.T will suspend share buybacks and skip a dividend hike to conserve cash, the Nikkei business daily said.
The company will keep its dividend payout at 180 yen per share... |
04fcbbe077d8d15225541c91dfa4c49a | https://www.reuters.com/article/rbssHealthcareNews/idUSBNG6675120091013 | Roche to review Genentech employees' pay -FT | Roche to review Genentech employees' pay -FT
By Reuters Staff2 Min Read
Oct 13 (Reuters) - Swiss drugmaker Roche Holding AG ROG.VX is likely to review the compensation policy for its staff at U.S. biotech unit Genentech, Chief Executive Severin Schwan told the Financial Times.
Genentech employees are likely to receive ... |
0e37b2c41b9b80d3b2283512b7515024 | https://www.reuters.com/article/rbssHealthcareNews/idUSBOM11751120090513 | India's Cipla says its generic flu drug on WHO list | India's Cipla says its generic flu drug on WHO list
By Reuters Staff1 Min Read
MUMBAI, May 13 (Reuters) - Indian drugmaker Cipla Ltd CIPL.BO said on Wednesday its 75 mg oseltamivir capsules, which has shown to be effective against the H1N1 flu virus, had been included in the World Health Organisation's list of pre-qual... |
00704da04e4b1695a0401e20539df816 | https://www.reuters.com/article/rbssHealthcareNews/idUSBOM34978220090502 | India Ranbaxy recalls Nitrofurantoin Capsules in U.S. | India Ranbaxy recalls Nitrofurantoin Capsules in U.S.
By Reuters Staff1 Min Read
MUMBAI, May 2 (Reuters) - India-based drug maker Ranbaxy Laboratories RANB.BO said on Saturday it is recalling all lots of Nitrofurantoin Capsules, an antibiotic, currently in the U.S. market.
A statement from the company said “certain lot... |
27226eed178d837838036c19c6a3064c | https://www.reuters.com/article/rbssHealthcareNews/idUSBOM48827020091023 | Pfizer taps Indian drug cos for alliances-report | Pfizer taps Indian drug cos for alliances-report
By Reuters Staff2 Min Read
MUMBAI, Oct 23 (Reuters) - U.S. drug firm Pfizer PFE.N has approached several Indian drugmakers for possible alliances to bolster its revenues, the Economic Times reported on Friday.
Pfizer has tapped Cadila Healthcare CADI.BO, Emcure, Intas Ph... |
206f67eb8652ac2a7d531f6b0d5ba086 | https://www.reuters.com/article/rbssHealthcareNews/idUSGEE5AO0HM20091125 | Roche CEO sees group outpacing market in 2009-paper | Roche CEO sees group outpacing market in 2009-paper
By Reuters Staff3 Min Read
* Roche CEO confident will meet new drugs sales goal
* Sees pharma unit gaining market share
ZURICH, Nov 25 (Reuters) - Swiss drugmaker Roche's ROG.VX pharma and diagnostics units will significantly outpace the market this year, the group's ... |
21dab279b61c78b4d940da5922425790 | https://www.reuters.com/article/rbssHealthcareNews/idUSL354278120090903 | UPDATE 1-Shire wins U.S. approval for Intuniv drug | UPDATE 1-Shire wins U.S. approval for Intuniv drug
By Reuters Staff2 Min Read
* FDA approves extended-release hyperactivity drug
* Intuniv to go on sale in November in U.S.
* Shire shares up 0.5 percent
(Adds details, background)
LONDON, Sept 3 (Reuters) - U.S. regulators approved Shire Plc's SHP.L extended-release hyp... |
6c06adbb653dfdc67e52b4833f1568b1 | https://www.reuters.com/article/rbssHealthcareNews/idUSL511205220090505?pageNumber=2&virtualBrandChannel=0 | UPDATE 3-Teva Q1 profit, sales rise, maintains outlook | UPDATE 3-Teva Q1 profit, sales rise, maintains outlook
By 4 Min Read
* Q1 non-GAAP earnings per share $0.71, beating forecasts
* Company seeks more acquisitions following Barr
* Maintains 2009, 2010 outlook
(Adds CFO quotes, analysts’ comments, outlook)
By Tova Cohen
TEL AVIV, May 5 (Reuters) - Teva Pharmaceutical Indu... |
06ebaded09612eb6c642d2fe26d2a059 | https://www.reuters.com/article/rbssHealthcareNews/idUSL541547720091105 | UPDATE 1-Ratiopharm owner says satisfied with bids | UPDATE 1-Ratiopharm owner says satisfied with bids
By 2 Min Read
* Number of bidders positive surprise - VEM
* VEM says “very satisfied” with level of bids
* Sale as whole remains priority
* Bidders comprise drugmakers and buyout firms
(Adds details, background)
FRANKFURT, Nov 5 (Reuters) - VEM, the owner of German gen... |
010557b267e04839f5914d3e83fbea3c | https://www.reuters.com/article/rbssHealthcareNews/idUSL564810320091005 | Sanofi to start selling own generic Plavix-report | Sanofi to start selling own generic Plavix-report
By Reuters Staff1 Min Read
PARIS, Oct 5 (Reuters) - Sanofi-Aventis SASY.PA will start selling its own generic version of its blood-clot treatment Plavix this week through its Winthrop unit, La Lettre de L'Expansion reports on Monday.
The move is aimed at beating other g... |
4b2b8cfd90f544517ab718d5be2998af | https://www.reuters.com/article/rbssHealthcareNews/idUSL6960620090506 | UPDATE 3-Crucell posts unexpected Q1 profit, outlook held | UPDATE 3-Crucell posts unexpected Q1 profit, outlook held
By 4 Min Read
* Q1 net profit 200,000 euros vs forecast 3 mln loss
* Reiterates FY outlook
* Earnings driven by sales of children’s vaccines
* Expects flu vaccine sales to rise in 2009
* Shares up 4.7 percent
(Adds spokeswoman’s comments, flu vaccine details)
By... |
7286723edc78f2f8867311e214fa99a8 | https://www.reuters.com/article/rbssHealthcareNews/idUSL698151520090506 | UPDATE 1-Adcock reaffirms friendly buy-out bid for CMSA | UPDATE 1-Adcock reaffirms friendly buy-out bid for CMSA
By Reuters Staff3 Min Read
* Says ready to buy CMSA without supply agreement
* Adcock surprised by supplier Cipla India’s rejection
* CMSA shares up nearly 3 pct
(Adds details, Cipla India’s comments)
JOHANNESBURG, May 6 (Reuters) - South Africa No.2 drug maker Ad... |
2fe7b27835e02e42551471641832c49e | https://www.reuters.com/article/rbssHealthcareNews/idUSL771967820090807 | UPDATE 1-Sanofi starts swine flu shot trial, files with FDA | UPDATE 1-Sanofi starts swine flu shot trial, files with FDA
By Reuters Staff2 Min Read
* Sanofi U.S. clinical trials started Aug. 6
* Supplemental vaccine application filed with FDA
(Adds details, background)
LONDON, Aug 7 (Reuters) - Sanofi-Aventis SASY.PA, the world leader in flu immunisation, said on Friday it start... |
94a73397e1ab41e30da3b3fcfdb0d531 | https://www.reuters.com/article/rbssHealthcareNews/idUSLA51378620090710 | UPDATE 2-Celesio board clears contested Brazil takeover | UPDATE 2-Celesio board clears contested Brazil takeover
By 3 Min Read
* Celesio to buy 50.1 percent stake in Panpharma
* Initial plan was to buy 54 percent
* Pays less than 150 million euros for stake -source
* Q2 EBITDA 150 million euros, down from 160 mln a year ago
* Shares up 0.9 percent
(Adds trading statement, an... |
719d465c13e18beeee2832b88a40c1c9 | https://www.reuters.com/article/rbssHealthcareNews/idUSLE6814820090414 | UPDATE 2-Ipsen's Botox rival faces U.S. marketing delay | UPDATE 2-Ipsen's Botox rival faces U.S. marketing delay
By Caroline Jacobs3 Min Read
* Ipsen, U.S. partner still in talks with FDA on Reloxin
* Original U.S. decision date was April 13
* Analysts say cosmetic, medical OK possible at same time (Adds company and analyst comment, shares, background)
PARIS, April 14 (Reute... |
a98f76458bd62a803981b003e576aef5 | https://www.reuters.com/article/rbssHealthcareNews/idUSLF73372620090715 | UPDATE 3-Sanofi says experts find Lantus studies flawed | UPDATE 3-Sanofi says experts find Lantus studies flawed
By 5 Min Read
* 14 experts say cancer studies inconclusive and conflicting
* More analysis of existing data, new research recommended
* Sanofi says “moving forward confidently” to resolve issue
* Sanofi shares gain 1.2 percent
(Adds analyst’s comments, more detail... |
74284a5a677c8128a1ec19d246f96d38 | https://www.reuters.com/article/rbssHealthcareNews/idUSLG14136620090416 | UPDATE 2-Sale of generic drugmaker Actavis halted -sources | UPDATE 2-Sale of generic drugmaker Actavis halted -sources
By 4 Min Read
* Disagreements on price, dearth of buyers scupper sale
* Follows series of failed asset auctions
* Actavis and Decode fallen stars of Icelandic drugs sector
(Adds details on Decode, background, Actavis comment)
By Quentin Webb
LONDON, April 16 (R... |
c60020a4aa504fa5d077797f515361a4 | https://www.reuters.com/article/rbssHealthcareNews/idUSLH64945620091118 | Doctors say most Britons reject swine flu vaccine | Doctors say most Britons reject swine flu vaccine
By Reuters Staff3 Min Read
* Poll shows only 46 pct of those offered vaccine say yes
* Doctors say pregnant women particularly reticent
LONDON, Nov 18 (Reuters) - More than half of Britons being offered vaccination against pandemic H1N1 flu are turning it down because t... |
c3d3f8d55dc84e607fca0ed33d685574 | https://www.reuters.com/article/rbssHealthcareNews/idUSLH67273520091117 | UPDATE 1-FDA warns Abbott over diagnostics manufacturing | UPDATE 1-FDA warns Abbott over diagnostics manufacturing
By Reuters Staff1 Min Read
* Manufacturing problems at Abbott Molecular plant
* Problems uncovered during June 2009 inspection
* Abbott says already taken steps to address problems (Adds Abbott comment, background)
WASHINGTON, Nov 17 (Reuters) - U.S. regulators h... |
ffdf1c8dace8ea7a0278fbdae0f804f3 | https://www.reuters.com/article/rbssHealthcareNews/idUSLI14460120090918 | UPDATE 2-Glaxo seen eyeing 5 pct stake in Dr Reddy's | UPDATE 2-Glaxo seen eyeing 5 pct stake in Dr Reddy's
By 4 Min Read
* Glaxo may pay $150 mln for stake, newspaper says
* Deal would be win-win for both drugmakers - analysts
* Dr Reddy’s shares up 3.6 pct, Glaxo gains 2 pct
* Glaxo, Dr Reddy’s decline to comment
(Adds reaction, Glaxo no comment, latest shares, backgroun... |
4fc8bf6bfa4c2add0182b44d3dba9e85 | https://www.reuters.com/article/rbssHealthcareNews/idUSLJ15898520090519 | UPDATE 2-EU court hurts Celesio expansion plan, shares sink | UPDATE 2-EU court hurts Celesio expansion plan, shares sink
By 4 Min Read
* EU ruling hits hopes for a German chain
* Court backs German legislation preventing expansion
* UCelesio says ruling provides clarity
* reiterates medium-term outlook
* Stock down 13.3 percent
(Adds comments from CEO, analyst, EU commission)
By... |
a30c82bc25d36c86fd1d00c20b22d81a | https://www.reuters.com/article/rbssHealthcareNews/idUSLJ93579020090519 | UPDATE 1-UK's Renovo to split Juvidex into two products | UPDATE 1-UK's Renovo to split Juvidex into two products
By Reuters Staff2 Min Read
* New formulation to be branded as Adaprev
* Adaprev to be developed as medical device
* Shares up 6 percent in thin volume
* Cash at half-year point 73.0 million pounds (Adds details)
LONDON, May 19 (Reuters) - Renovo Group Plc RNVO.L, ... |
8b47ee0cf9e429cbbee811d1935a1088 | https://www.reuters.com/article/rbssHealthcareNews/idUSLL95293820090521 | PREVIEW-Decision time for Bayer and Glaxo drugs in U.S. | PREVIEW-Decision time for Bayer and Glaxo drugs in U.S.
By Ben Hirschler4 Min Read
* FDA verdict due on Bayer/J&J drug Xarelto by May 28
* U.S. panel meets on Glaxo/Genmab’s Arzerra on May 29
* Xarelto may face delay; Arzerra expected to be recommended
LONDON, May 21 (Reuters) - A crunch week looms for Bayer BAYG.DE an... |
daa01ddc4b5cd15ec9dbfbb478e05d47 | https://www.reuters.com/article/rbssHealthcareNews/idUSLM26390920090522 | UPDATE 1-SkyePharma lung drug accepted for FDA review | UPDATE 1-SkyePharma lung drug accepted for FDA review
By Reuters Staff2 Min Read
* Flutiform accepted for review by U.S. regulator
* Potential blockbuster may be approved in 2010
* Shares up 8.5 percent
(Adds analyst comment, shares, background)
LONDON, May 22 (Reuters) - SkyePharma SKP.L moved a step closer to getting... |
6da193be58e590e43098782fb6c943fb | https://www.reuters.com/article/rbssHealthcareNews/idUSLN33323320090723 | Slovenia to buy H1N1 flu vaccine from GSK and Novartis | Slovenia to buy H1N1 flu vaccine from GSK and Novartis
By Reuters Staff1 Min Read
LJUBLJANA, July 23 (Reuters) - Euro zone member Slovenia will buy a total of 1.3 million units of H1N1 flu vaccine from Britain's GlaxoSmithKline GSK.L (GSK) and Switzerland's Novartis NOVN.VX, Health Minister Borut Miklavcic said on Thur... |
563f0431795bc799ddd132ff16685582 | https://www.reuters.com/article/rbssHealthcareNews/idUSLO18352620090424 | Roche and Astra face tussle over lung cancer pills | Roche and Astra face tussle over lung cancer pills
By Ben Hirschler3 Min Read
* Roche to test Tarceva in EGFR-mutant lung cancer patients
* Move comes day after EU recommendation for Astra’s Iressa
* Both drugs targeted therapies, alternative to chemotherapy
LONDON, April 24 (Reuters) - Roche Holding AG ROG.VX is to te... |
19fff121ba1e9d875b8245cd13c06bdb | https://www.reuters.com/article/rbssHealthcareNews/idUSLP23182420090825 | Industry blames price gap for UK drug shortages | Industry blames price gap for UK drug shortages
By Reuters Staff2 Min Read
* Medicine exports jump due to low prices and weak pound
* Surge in emergency deliveries to pharmacies to plug gap
LONDON, Aug 25 (Reuters) - A widening price gap, fuelled by a weak pound, is behind the current shortage of some medicines in Brit... |
e531eba86dd3d4bbab3e0d677a705ce4 | https://www.reuters.com/article/rbssHealthcareNews/idUSLU30775320090730?pageNumber=2&virtualBrandChannel=10522 | UPDATE 4-Sanofi buys rest of Merial from Merck for $4 bln | UPDATE 4-Sanofi buys rest of Merial from Merck for $4 bln
By 5 Min Read
* Sanofi buys 50 percent of Merial
* Says will boost earnings from first year
* Option to combine Merial, Merck/Schering animal health
* Option valued at least at $9.25 billion
* Price viewed as hefty, shares up 0.2 percent (Adds bankers, analyst c... |
3d539a6de026a594f87479add2533c25 | https://www.reuters.com/article/rbssHealthcareNews/idUSLU63456120090831 | Astra's Crestor shows preventive effect in elderly | Astra's Crestor shows preventive effect in elderly
By Reuters Staff2 Min Read
* Over 70s see 39 pct risk reduction in trial
* New analysis may widen drug use in elderly
BARCELONA, Aug 31 (Reuters) - AstraZeneca's AZN.L anti-cholesterol drug Crestor cuts the risk of heart attacks, strokes, artery-clearing procedures and... |
936aeccbe477bbef450db7e0eb91355e | https://www.reuters.com/article/rbssHealthcareNews/idUSLV20847420091031 | Sanofi wants to double vaccine business-paper | Sanofi wants to double vaccine business-paper
By Reuters Staff1 Min Read
FRANKFURT, Oct 31 (Reuters) - Sanofi-Aventis SASY.PA wants to double its vaccine business in the next five years, its chief executive told a German newspaper on Saturday.
“We want to double it in the next five years. Its share in group sales will ... |
c8d4c024ae29858def23d3456225b28b | https://www.reuters.com/article/rbssHealthcareNews/idUSN0250356320090602 | Glaxo gets U.S. antitrust approval for Stiefel | Glaxo gets U.S. antitrust approval for Stiefel
By Reuters Staff1 Min Read
WASHINGTON, June 2 (Reuters) - GlaxoSmithKline GSK.L received U.S. antitrust approval to buy privately-held skincare company Stiefel Laboratories Inc, U.S. officials said on Tuesday.
Antitrust authorities completed their review of the deal worth ... |
81d0bbe293dd761cdc71ac751054c563 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0254527220090602 | Heart drug may block breast cancer gene | Heart drug may block breast cancer gene
By Reuters Staff2 Min Read
WASHINGTON, June 2 (Reuters) - A gene that is highly active in up to 20 percent of breast cancer cases might be blocked by a generically available blood pressure drug, U.S. researchers reported on Tuesday.
The gene, called AGTR1, caused normal breast ce... |
fb3649872c6645f71a49fa22336c5097 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0350270520091103 | UPDATE 2-Merck, Schering-Plough set to complete merger | UPDATE 2-Merck, Schering-Plough set to complete merger
By Reuters Staff3 Min Read
* Will begin combined operations on Wednesday
* Deal follows October Pfizer-Wyeth close
* Merck shares down 2.1 pct (Adds details on merger, ongoing dispute with J&J)
NEW YORK, Nov 3 (Reuters) - Merck & Co MRK.N and Schering-Plough Corp S... |
db26ae74ffdd2a05e5aaaeecf12698ca | https://www.reuters.com/article/rbssHealthcareNews/idUSN0424298320090604 | Express Scripts launches $2.5 bln 3-part sale - IFR | Express Scripts launches $2.5 bln 3-part sale - IFR
By Reuters Staff1 Min Read
NEW YORK, June 4 (Reuters) - Express Scripts Inc ESRX.O on Thursday launched its three-part $2.5 billion note sale, said IFR, a Thomson Reuters service.
The offering includes $1.0 billion each in three-year and five-year notes, both expected... |
03331c31db17847782ccd7c1d03c1332 | https://www.reuters.com/article/rbssHealthcareNews/idUSN044840020091104 | US STOCKS-Wall St advances after Fed's statement | US STOCKS-Wall St advances after Fed's statement
By 3 Min Read
* Investors eye FOMC statement on rates and economy
* Services sector up for second month in a row
* U.S. private sector sheds jobs at slowest pace in yr
* Dow up 1 pct, S&P up 0.7 pct, Nasdaq up 0.2 pct
* For up-to-the-minute market news, click [STXNEWS/US... |
2e2b219c9313674c99b8dbe0441e9e10 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0634363820090806 | Bill Clinton, drugmakers announce cheaper HIV drugs | Bill Clinton, drugmakers announce cheaper HIV drugs
By Reuters Staff2 Min Read
NEW YORK, Aug 6 (Reuters) - Former U.S. President Bill Clinton and drugmakers Pfizer PFE.N and Matrix Laboratories Ltd MAXL.BO announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
S... |
51b4130d254b98541f877bf7a5befda9 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0644662320091006?sp=true | U.S. study shows mammograms save lives | U.S. study shows mammograms save lives
By Maggie Fox, Health, Science Editor3 Min Read
* 75 percent of women who died had not had mammograms
* Only 25 percent of regularly screened women died
WASHINGTON, Oct 6 (Reuters) - Women who never got mammograms are far more likely to die of breast cancer than women who are regu... |
376ca64d1a9829f4d51e1fadc0c73d62 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0646293320091106 | UPDATE 1-Abbott faces new US sales probe, Depakote in focus | UPDATE 1-Abbott faces new US sales probe, Depakote in focus
By Ransdell Pierson3 Min Read
* U.S. probing whether sales violated anti-kickback law
* Probe also examines possible false claims
* Involves Medicare, Medicaid payments to third parties
NEW YORK, Nov 6 (Reuters) - Federal officials are investigating how Abbott... |
150e3f4a2579710fcd47c8cf2305e2ee | https://www.reuters.com/article/rbssHealthcareNews/idUSN0735445720090507 | UPDATE 2-Obama seeks US FDA budget hike, generic drug fees | UPDATE 2-Obama seeks US FDA budget hike, generic drug fees
By Susan Heavey, Lisa Richwine3 Min Read
* Proposal calls for FDA budget topping $3 bln
* Seeks funds to get cheaper medications to market (Adds background, DeLauro comment, details of budget proposal)
WASHINGTON, May 7 (Reuters) - President Barack Obama propos... |
ebbf9c25f7488c94ac9b6b1269d916e0 | https://www.reuters.com/article/rbssHealthcareNews/idUSN0948398720090710 | UPDATE 2-FDA OKs widened use of Merck's Isentress HIV drug | UPDATE 2-FDA OKs widened use of Merck's Isentress HIV drug
By Ransdell Pierson2 Min Read
* Isentress approved for previously untreated patients
* Merck says safety profile could be drawing card
* Merck shares little changed in after-hours trade (Adds shares)
NEW YORK, July 9 (Reuters) - Merck & Co MRK.N on Thursday sai... |
ea9bac91006a530c4aaf2089ce622ea2 | https://www.reuters.com/article/rbssHealthcareNews/idUSN1250608420090819 | UPDATE 2-Court upholds validity of Merck's Singulair patent | UPDATE 2-Court upholds validity of Merck's Singulair patent
By Ransdell Pierson2 Min Read
* U.S. judge upholds Merck’s Singulair patent
* Rules Teva’s generic version infringes Merck patent (Updates with Merck, Teva comment, details)
NEW YORK, Aug 19 (Reuters) - A U.S. federal judge upheld the validity of a patent on M... |
4b70b5286b39232c771461e0156b61a2 | https://www.reuters.com/article/rbssHealthcareNews/idUSN1342334820090513 | UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing
By Reuters Staff2 Min Read
* FDA says journal reprint is misleading
* Materials overstated Taxotere’s benefits -FDA
* Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7)
WASHINGTON, May 13 (Reuters) - U.S. health regulators ... |
060cf41d964f28d1381a9f546927b6dc | https://www.reuters.com/article/rbssHealthcareNews/idUSN1528773820091015 | UPDATE 4-Baxter earnings rise, but sales flat and stock off | UPDATE 4-Baxter earnings rise, but sales flat and stock off
By 4 Min Read
* Q3 net up 12 pct, but sales flat from a year ago
* Sales fall below Street view, FX weighs
* Shares fall 3.5 percent
* To record $30 mln to $40 mln in H1N1 vaccine sales in Q4 (Adds conference call, more comment, byline, updates stock)
By Debra... |
166b522f916ad9217c186d3aeb97737e | https://www.reuters.com/article/rbssHealthcareNews/idUSN1547231120091116 | UPDATE 2-Bristol-Myers to spin off Mead stock | UPDATE 2-Bristol-Myers to spin off Mead stock
By Reuters Staff3 Min Read
(Adds background on Mead IPO)
NEW YORK, Nov 15 (Reuters) - Bristol-Myers Squibb Co BMY.N said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company MJN.N in a deal that lets Bristol shareholders exchange their shar... |
56be02343d310bd9c4462e606aa83eb2 | https://www.reuters.com/article/rbssHealthcareNews/idUSN1639595620090716 | CORRECTED-UPDATE 4-Baxter net beats Street view | CORRECTED-UPDATE 4-Baxter net beats Street view
By 4 Min Read
(Corrects to remove extraneous words from paragraph two)
* Q2 shr 96 cents vs 85 cents year ago; beats Street view
* Quarterly sales dip 2 pct; foreign exchange rates weigh
* Raises full-year outlook
* First H1N1 vaccine batch ready by late July/early August... |
8393c922229def38cd9e76f52a61e663 | https://www.reuters.com/article/rbssHealthcareNews/idUSN1737499420091117 | UPDATE 2-US FDA sees varying risk from MRI agents | UPDATE 2-US FDA sees varying risk from MRI agents
By Lisa Richwine4 Min Read
* Risk seen highest with GE’s Omniscan, Bayer’s Magnevist
* FDA to bring issue to December advisory panel
* FDA staff want labels to reflect varying risk levels (Recasts first paragraph to emphasize some agents carry higher risk; adds company ... |
87778bacea865b056f0f4e2033a015a3 | https://www.reuters.com/article/rbssHealthcareNews/idUSN175092620091117 | UPDATE 1-Polpharma and Bioton to work on possible merger | UPDATE 1-Polpharma and Bioton to work on possible merger
By Reuters Staff1 Min Read
* Polpharma could buy antibiotic unit of Bioton
* Subject to study, could sign merger plan by Aug. 30 (Adds price estimate in paragraph 2)
WARSAW, Nov 17 (Reuters) - Polish pharmaceutical groups Polpharma and Bioton BOTN.WA will work on... |
0543e4331b0febe786c37c0264085763 | https://www.reuters.com/article/rbssHealthcareNews/idUSN1825532420090918 | UPDATE 1-Apotex recalls certain lots of 3 drugs in Canada | UPDATE 1-Apotex recalls certain lots of 3 drugs in Canada
By Reuters Staff3 Min Read
* Apo-Amilzide, Apo-Meloxicam, Apo-Ranitidine recalled
* Recall is voluntary, precautionary
* Health Canada continues inspections of Apotex facilities (Adds company comments)
OTTAWA, Sept 18 (Reuters) - Prescription drugmaker Apotex In... |
ccec9541efb602a3b7bd4e974b8e074f | https://www.reuters.com/article/rbssHealthcareNews/idUSN1949135120090819 | UPDATE 1-Tests help lung cancer drugs reach right patients | UPDATE 1-Tests help lung cancer drugs reach right patients
By Julie Steenhuysen4 Min Read
* In right patients, Iressa is better as first treatment
* Study in European patients shows Tarceva benefit (Adds company comments, paragraphs 15-17)
CHICAGO, Aug 19 (Reuters) - Diagnostic tests that look for specific genetic or m... |
2ef2fb70f99e06588f3f6d7eceaedc05 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2014397320090720 | UPDATE 2-Boston Scientific profit up, shares jump | UPDATE 2-Boston Scientific profit up, shares jump
By Susan Kelly, Bill Berkrot4 Min Read
* Q2 adj profit of 20 cts/share beats analysts’ estimate
* Shares rise nearly 7 percent in after-hours trading
(Adds earnings details, analyst comments)
CHICAGO, July 20 (Reuters) - Boston Scientific Corp BSX.N said on Monday its q... |
134a1a3e5c82d4d23a099f5459701182 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2143735320091021 | UPDATE 4-Lilly profit tops Street view, but shares fall | UPDATE 4-Lilly profit tops Street view, but shares fall
By 5 Min Read
* Q3 EPS ex-items $1.20; Wall Street view $1.02
* Q3 revenue rises 7 pct to $5.56 bln; St view $5.41 bln
* Raises FY profit forecast to $4.30-$4.40/share ex-items
* Inventory benefit to margins not seen continuing
* Shares fall nearly 3 percent (Reca... |
a22402ca0e2ed348929ba7e3d3d757a3 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2359635720090723 | New Issue-St Jude Medical sells $1.2 bln in two parts | New Issue-St Jude Medical sells $1.2 bln in two parts
By Reuters Staff0 Min Read
July 23 (Reuters) - St Jude Medical Inc STJ.N on Thursday sold $1.2 billion in a two-part debt sale, said IFR, a Thomson Reuters service.
Bank of America, Goldman Sachs, Mitsubishi, and Wells Fargo Securities were the joint bookrunning man... |
1a663d9b5f6f3505c72ca1543dc53502 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2629646920080326 | UPDATE 1-Lilly settles Zyprexa case with Alaska for $15 mln | UPDATE 1-Lilly settles Zyprexa case with Alaska for $15 mln
By Reuters Staff2 Min Read
(Adds details in paragraphs 2-4; adds paragraphs 5-10)
NEW YORK, March 26 (Reuters) - Eli Lilly and Co LLY.N on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible... |
eb77ae697b67ae74bb1a7498296c5947 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2834503720090429 | REFILE-UPDATE 5-Medco posts higher net, keeps forecast | REFILE-UPDATE 5-Medco posts higher net, keeps forecast
By 5 Min Read
(Refiles to fix stock symbol (RIC) format in paragraph 1)
* Q1 EPS 63 cents ex items vs 62-cent Wall St estimate
* Backs 2009 profit forecast
* Prescription volume up 9.4 percent
* Shares fall 3 pct (Adds CFO comment from interview, updates shares)
By... |
98fdb632e0f5bbdb940b5db7600e83c7 | https://www.reuters.com/article/rbssHealthcareNews/idUSN2940302320090629?pageNumber=1&virtualBrandChannel=0 | Diabetics urged to stay on popular insulin Lantus | Diabetics urged to stay on popular insulin Lantus
By Julie Steenhuysen3 Min Read
* Doctors brace for calls from worried patients
* Lantus findings “not an emergency”
CHICAGO, June 29 (Reuters) - Dr. Louis Philipson has already started fielding calls from worried diabetics after new studies of 300,000 patients released ... |
d0aa5317afbb736f91fb47350b30795c | https://www.reuters.com/article/rbssHealthcareNews/idUST18632620090415 | UPDATE 1-Japan's Santen licenses glaucoma drug to Merck & Co | UPDATE 1-Japan's Santen licenses glaucoma drug to Merck & Co
By Reuters Staff2 Min Read
* Merck to sell Santen eye drug in Americas, western Europe
* Santen keeps Germany, eastern, northern Europe and Asia
TOKYO, April 15 (Reuters) - Japan's Santen Pharmaceutical Co 4536.OS agreed to license to Merck & Co Inc MRK.N its... |
196e1d4d5e6e970f8bcb2d49504531c2 | https://www.reuters.com/article/rbssHealthcareNews/idUST22651820090513 | UPDATE 2-Astellas forecasts profit fall on forex, R&D costs | UPDATE 2-Astellas forecasts profit fall on forex, R&D costs
By 4 Min Read
* Sees annual profit down 19 pct, below analyst forecasts
* Stronger yen, drug development costs to weigh on profits
* Reviewing profit targets for year to March 2011
* Shares close up 2.1 pct before announcement
By Yumiko Nishitani
TOKYO, May 13... |
3e255f83f320214da56afc57a3380cfb | https://www.reuters.com/article/rbssHealthcareNews/idUST34424920090811 | UPDATE 2-Novartis hits Astellas with transplant drug generic | UPDATE 2-Novartis hits Astellas with transplant drug generic
By Reuters Staff4 Min Read
* Novartis launches first generic version of Prograf
* Astellas to challenge FDA over Prograf in court
* Astellas shares down 5 pct vs 0.4 pct fall for sector
* Analysts see mild falls in Prograf sales
TOKYO, Aug 11 (Reuters) - Swis... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.